Addition/Correction pubs.acs.org/jmc
Correction to Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonist Andreas Evers,* Torsten Haack, Martin Lorenz, Martin Bossart, Ralf Elvert, Bernd Henkel, Siegfried Stengelin, Michael Kurz, Maike Glien, Angela Dudda, Katrin Lorenz, Dieter Kadereit, and Michael Wagner* Journal of Medicinal Chemistry 2017, 60, 4293−4303. DOI: 10.1021/acs.jmedchem.7b00174 Page 4294. In the left-hand column in the first full paragraph below Table 1, “Day et al.,17” should be “Day et al.,50” and “Henderson et al. (MedImmune).18” should be “Henderson et al. (MedImmune).17”, as displayed below: Such dual GLP-1/glucagon receptor agonists that are additionally stabilized by chemical modifications have been described, for example, by Pocai et al.,11,12 Flatt et al.,13−16 Day et al.,50 and most recently by Henderson et al. (MedImmune).17 Page 4303. The following ref 50 should be added: Day, J. W.; Ottaway, N.; Patterson, J. T.; Gelfanov, V.; Smiley, D.; Gidda, J.; Findeisen, H.; Bruemmer, D.; Drucker, D. J.; Chaudhary, N.; Holland, J.; Hembree, J.; Abplanalp, W.; Grant, E.; Ruehl, J.; Wilson, H.; Kirchner, H.; Lockie, S. H.; Hofmann, S.; Woods, S. C.; Nogueiras, R.; Pfluger, P. T.; Perez-Tilve, D.; DiMarchi, R.; Tschöp, M. H. Nat. Chem. Biol. 2009, 5, 749−757.
© XXXX American Chemical Society
A
DOI: 10.1021/acs.jmedchem.7b00887 J. Med. Chem. XXXX, XXX, XXX−XXX
